A cautious B2B guide to Oligopeptide-1, sh-Oligopeptide-1 and EGF-positioned cosmetic serums. Written for cosmetic brands, formulators, distributors and professional B2B buyers.
Why terminology matters
Oligopeptide-1, sh-Oligopeptide-1 and EGF are often grouped together online, but they should not be assumed to be identical regulatory or technical materials. A product name, INCI entry and biological-growth-factor description can carry different implications. Buyers must identify the exact supplied material and permitted market use.
Request a complete identity file
Ask for INCI name, sequence or recombinant-source information where relevant, manufacturer code, active-content basis, carrier, preservative, specification, COA, SDS and storage. Confirm whether the item is a cosmetic oligopeptide, a recombinant human-sequence material or a proprietary blend.
Cold handling and processing
Some oligopeptide grades may be heat sensitive and require controlled cool-down addition or refrigerated storage. Follow the exact supplier guidance, record time out of storage and avoid repeated freeze-thaw cycles unless supported. Validate the process at pilot scale.
Vehicle and packaging
A water-based serum requires robust preservation and compatible packaging. Proteinaceous or peptide materials may interact with surfaces, preservatives or other actives. Monitor appearance, pH, odor, viscosity and a suitable identity or potency marker when justified.
Evidence requires careful reading
Reviews of topical growth factors and critical analyses of sh-Oligopeptide-1 highlight substantial differences among preparations and studies. Evidence from one recombinant material or professional procedure cannot automatically substantiate a retail cosmetic serum.
Claims and regulatory review
Avoid drug-like language about healing wounds, regenerating tissue or changing cell growth. Destination-market classification and claims review should occur before artwork. If the product is intended for professional post-procedure use, obtain specialist safety and regulatory advice.
Buyer decision
Proceed only when the supplier can clearly explain identity, production source, test method, storage, batch documentation and permitted cosmetic positioning. Ambiguous “EGF” marketing is not a substitute for a technical specification.
Selected research for further reading
These sources provide background and do not substitute for finished-product substantiation.
Need a product-specific specification?
Send the peptide, format, quantity, packaging and destination market. We will confirm composition, MOQ, documents and sample options.
Ask the B2B TeamPublished August 12, 2026. Educational B2B content; not medical advice.